Aker BioMarine ASA (OSL:AKBM)
78.00
-0.90 (-1.14%)
Aug 5, 2025, 3:41 PM CET
Verve Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Cash & Equivalents | 19.5 | 15 | 27.5 | 22.3 | 11.1 | 10.68 | Upgrade |
Cash & Short-Term Investments | 19.5 | 15 | 27.5 | 22.3 | 11.1 | 10.68 | Upgrade |
Cash Growth | 19.63% | -45.45% | 23.32% | 100.90% | 3.95% | -21.54% | Upgrade |
Accounts Receivable | 51.4 | 47.3 | 57.6 | 59.9 | 50.3 | 53.72 | Upgrade |
Other Receivables | - | 1.8 | 8.3 | 5.2 | 10.1 | 10.39 | Upgrade |
Receivables | 53.1 | 50 | 66.2 | 65.1 | 60.4 | 64.11 | Upgrade |
Inventory | 101.8 | 96.3 | 183.7 | 196.6 | 138.2 | 114.56 | Upgrade |
Prepaid Expenses | - | 5.1 | 5.6 | 3.7 | 17.3 | 33.78 | Upgrade |
Other Current Assets | 20.1 | 35.3 | 7.1 | 11 | 12.5 | -0 | Upgrade |
Total Current Assets | 194.5 | 201.7 | 290.1 | 298.7 | 239.5 | 223.12 | Upgrade |
Property, Plant & Equipment | 56.3 | 51.6 | 350.6 | 343.1 | 339.2 | 279.7 | Upgrade |
Long-Term Investments | 0.4 | 0.4 | 0.1 | 10.2 | 0.1 | 0.13 | Upgrade |
Goodwill | 62.6 | 62.6 | 94.7 | 94.6 | 94.6 | 94.61 | Upgrade |
Other Intangible Assets | 41.9 | 46.2 | 56.5 | 64.1 | 74 | 85.87 | Upgrade |
Long-Term Deferred Tax Assets | 2.2 | 5.7 | 25 | - | - | - | Upgrade |
Long-Term Deferred Charges | 17.8 | 15.8 | 7.4 | 9.2 | 10.1 | 9.24 | Upgrade |
Other Long-Term Assets | 7.3 | 0.1 | - | - | - | 7.76 | Upgrade |
Total Assets | 387 | 387.4 | 827.1 | 822.4 | 757.5 | 700.43 | Upgrade |
Accounts Payable | 46.1 | 16.3 | 30.1 | 39 | 25.3 | 20.25 | Upgrade |
Accrued Expenses | - | 23 | 31.4 | 14.9 | 17.6 | 15.22 | Upgrade |
Short-Term Debt | 24.7 | 5.8 | 14.7 | 33.4 | 16.9 | 12.67 | Upgrade |
Current Portion of Long-Term Debt | - | - | 29.4 | 9.4 | 9.4 | 12.01 | Upgrade |
Current Portion of Leases | - | 1.4 | 4.9 | 4.8 | 4.4 | 7.54 | Upgrade |
Other Current Liabilities | 3.3 | 6.7 | 2.4 | 3.2 | 3.7 | 3.24 | Upgrade |
Total Current Liabilities | 74.1 | 53.2 | 112.9 | 104.7 | 77.3 | 70.94 | Upgrade |
Long-Term Debt | 158.4 | 138.7 | 339.2 | 327.8 | 286.6 | 204.34 | Upgrade |
Long-Term Leases | - | 1.6 | 4.8 | 5.8 | 7.5 | 6.23 | Upgrade |
Long-Term Deferred Tax Liabilities | 4.9 | 8.3 | 3.7 | 5.4 | 4.9 | 4.82 | Upgrade |
Other Long-Term Liabilities | - | 11.7 | - | -0.1 | 10.6 | 40.74 | Upgrade |
Total Liabilities | 237.4 | 213.5 | 460.6 | 443.7 | 387.1 | 327.26 | Upgrade |
Common Stock | 75.9 | 75.9 | 75.9 | 75.9 | 75.9 | 75.85 | Upgrade |
Additional Paid-In Capital | 530.4 | 530.3 | 530.1 | 530 | 529.9 | 529.9 | Upgrade |
Retained Earnings | -420.2 | -396.3 | -203.3 | -194.4 | -204.4 | -196.38 | Upgrade |
Comprehensive Income & Other | -36.5 | -36 | -36.2 | -32.8 | -31 | -36.2 | Upgrade |
Shareholders' Equity | 149.6 | 173.9 | 366.5 | 378.7 | 370.4 | 373.17 | Upgrade |
Total Liabilities & Equity | 387 | 387.4 | 827.1 | 822.4 | 757.5 | 700.43 | Upgrade |
Total Debt | 183.1 | 147.5 | 393 | 381.2 | 324.8 | 242.8 | Upgrade |
Net Cash (Debt) | -163.6 | -132.5 | -365.5 | -358.9 | -313.7 | -232.12 | Upgrade |
Net Cash Per Share | -1.88 | -1.51 | -4.17 | -4.10 | -3.58 | -2.97 | Upgrade |
Filing Date Shares Outstanding | 86.93 | 87.69 | 87.67 | 87.64 | 87.59 | 87.59 | Upgrade |
Total Common Shares Outstanding | 86.93 | 87.69 | 87.67 | 87.64 | 87.59 | 87.59 | Upgrade |
Working Capital | 120.4 | 148.5 | 177.2 | 194 | 162.2 | 152.18 | Upgrade |
Book Value Per Share | 1.72 | 1.98 | 4.18 | 4.32 | 4.23 | 4.26 | Upgrade |
Tangible Book Value | 45.1 | 65.1 | 215.3 | 220 | 201.8 | 192.69 | Upgrade |
Tangible Book Value Per Share | 0.52 | 0.74 | 2.46 | 2.51 | 2.30 | 2.20 | Upgrade |
Buildings | 23.6 | 23.6 | 20.6 | 19.6 | 18.8 | 18.62 | Upgrade |
Machinery | 73.8 | 62.3 | 469.8 | 432.7 | 448.6 | 363.94 | Upgrade |
Construction In Progress | 3.6 | 8.8 | 46.5 | 46.5 | 25.7 | 12.48 | Upgrade |
Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.